Elevated serum adiponectin levels may indicate a higher risk of poorer transplant-free survival, underscoring the importance of additional research to confirm these results and investigate the mechanisms through which adiponectin affects the progression and outcomes of liver disease. Here, ADIPOQ is linked to liver disorder.